Carbapenem-resistant Pseudomonas aeruginosa infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China

被引:13
|
作者
Huang, Weichun [1 ]
Wei, Xiaoshu [2 ]
Xu, Guifeng [3 ]
Zhang, Xingyu [1 ]
Wang, Xing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Lab Med, Shanghai, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Nursing, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
carbapenem-resistant Pseudomonas aeruginosa; pediatric; risk factor; mortality; antimicrobial resistance; INTENSIVE-CARE-UNIT; NOSOCOMIAL INFECTIONS; EPIDEMIOLOGY; SURVEILLANCE; SEPSIS;
D O I
10.3389/fpubh.2023.1088262
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and aimsCarbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major cause of healthcare-associated infections worldwide, but comprehensive study of clinical characteristics for CRPA infections among critically ill children remains limited in China. The objective of this study was to determine the epidemiology, risk factors, and clinical outcomes of CRPA infections among critically ill pediatric patients in a large tertiary pediatric hospital in China. MethodsA retrospective case-control study of patients with P. aeruginosa infections was conducted in the three intensive care units (ICUs) of Shanghai Children's Medical Center from January 2016 to December 2021. All patients with CRPA infection in the ICUs were enrolled as case patients. Patients with carbapenem-susceptible P. aeruginosa (CSPA) infection were randomly selected as control patients in a ratio of 1:1. Clinical characteristics of those inpatients were reviewed through the hospital information system. Univariate and multivariate analyses were performed to evaluate risk factors associated with the development of CRPA infections and mortality of P. aeruginosa infections. ResultsA total of 528 cases of P. aeruginosa infection in the ICUs were enrolled in the 6-year study. The prevalence of CRPA and MDRPA (multidrug-resistance P. aeruginosa) was 18.4 and 25.6%, respectively. Significant risk factors related to CRPA infection were the length of hospitalization >28 days (OR = 3.241, 95% CI 1.622-6.473, p = 0.001), receiving invasive operations (OR = 2.393, 95% CI 1.196-4.788, p = 0.014) and a blood transfusion (OR = 7.003, 95% CI 2.416-20.297, p < 0.001) within 30 days before infection. Conversely, birth weight >= 2,500 g (OR = 0.278, 95% CI 0.122-0.635, p = 0.001) and breast nursing (OR = 0.362, 95% CI 0.168-0.777, p = 0.009) were significant protective factors against CRPA infections. The in-hospital mortality rate was 14.2%, and no difference in mortality was observed between patients with CRPA and CSPA infections. Platelet < 100 x 10(9)/L (OR = 5.729, 95% CI 1.048-31.308, p = 0.044) and serum urea <3.2 mmol/L (OR = 5.173, 95% CI 1.215-22.023, p = 0.026) were independent predictors for the mortality due to P. aeruginosa infection. ConclusionsOur findings provide insights into CRPA infections among critically ill children in China. They provide guidance in identifying patients that may be at high risk for a resistant infection and emphasize the importance of antimicrobial stewardship and infection control in hospitals.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study
    Verma, Gaurav
    Nayak, Subham Ravi
    Jena, Swetapadma
    Panda, Subhra Snigdha
    Pattnaik, Dipti
    Praharaj, A. K.
    Singh, Nipa
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2023, 17 (04): : 2243 - 2249
  • [22] Risk Factors and Outcomes of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infection
    Wei, Xianzhen
    Li, Linlin
    Li, Meng
    Liang, Hongjie
    He, Yu
    Li, Shan
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 337 - 346
  • [23] Non-carbapenem-producing carbapenem-resistant Pseudomonas aeruginosa in children: Risk factors, molecular epidemiology, and resistance mechanism
    Yin, Lijun
    Lu, Lu
    He, Leiyan
    Yan, Gangfeng
    Lu, Guoping
    Zhai, Xiaowen
    Wang, Chuanqing
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2025, 18 (02)
  • [24] Correlation between Rates of Carbapenem Consumption and the Prevalence of Carbapenem-Resistant Pseudomonas aeruginosa in a Tertiary Care Hospital in Brazil: A 4-Year Study
    Furtado, Guilherme H. C.
    Perdiz, Luciana B.
    Onita, Julio H.
    Wey, Sergio B.
    Medeiros, Eduardo A. S.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (06): : 664 - 666
  • [25] Risk Factors for and Clinical Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Nosocomial Infections: A Retrospective Study in a Tertiary Hospital in Beijing, China
    Zhang, Huijuan
    Guo, Zhe
    Chai, Yan
    Fang, Yi-Peng
    Mu, Xiangdong
    Xiao, Nan
    Guo, Jun
    Wang, Zhong
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 1393 - 1401
  • [26] High mortality outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a Brazilian pediatric oncology hospital
    Quiles, Milene Goncalves
    Carlesse, Fabianne
    Aguiar da Silva, Maria Aparecida
    Mingrone, Roberta Cabral
    Fonseca, Juliane Melo
    Silva, Dafne Cardoso
    Campos Pignatari, Antonio Carlos
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2017, 21 (02): : 205 - 206
  • [27] Risk factors for mortality in hospitalized patients infected with carbapenem-resistant Pseudomonas aeruginosa in Iran
    Khalili, Younes
    Omidnia, Pooya
    Goli, Hamid Reza
    Zamanlou, Sajjad
    Babaie, Farhad
    Bialvaei, Abed Zahedi
    GERMS, 2022, 12 (03): : 344 - 351
  • [28] Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa
    Tsao, Li-Hsin
    Hsin, Chih-Yi
    Liu, Hsin-Yi
    Chuang, Han-Chuan
    Chen, Li-Yuan
    Lee, Yuarn-Jang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (03) : 359 - 366
  • [29] Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
    Buehrle, Deanna J.
    Shields, Ryan K.
    Clarke, Lloyd G.
    Potoski, Brian A.
    Clancy, Cornelius J.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [30] Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa
    Tsao, Li-Hsin
    Hsin, Chih-Yi
    Liu, Hsin-Yi
    Chuang, Han-Chuan
    Chen, Li-Yuan
    Lee, Yuarn-Jang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S139 - S140